ID

24772

Beschreibung

Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00569114

Link

https://clinicaltrials.gov/show/NCT00569114

Stichworte

Versionen (1)
  1. 16.08.17 16.08.17 -
Hochgeladen am

16. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-small Cell Lung Cancer NCT00569114

Englisch

Eligibility Non-small Cell Lung Cancer NCT00569114

1 Formulare  
Criteria
Beschreibung

Criteria

histogically or pathologically determined relapsed/recurrent stage iiib (plueral effusion) or iv nsclc.
Beschreibung

Non-small cell lung cancer recurrent TNM clinical staging | Pleural effusion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0278517
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0032227
measurable or evaluable disease as defined by recist
Beschreibung

Measurable Disease | Evaluable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
must have failed at least one prior chemotherapy regimen or have refused chemotherapy.
Beschreibung

Chemotherapy Regimen Quantity failed | Chemotherapy Refused

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1705116
ecog perfromance status of 0,1, or 2.
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
exclusion criteria (include but are not limited to):
Beschreibung

Exclusion Criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
radiation therapy (excluding cns therapy) < 2 weeks, chemotherapy, non-cytotoxic investigational agents or high dose corticosteroids within 3 weeks of intitating therpy or patients who have not recovered from adverse effects due to agents administered more than 3 weeks earlier.
Beschreibung

Therapeutic radiology procedure | Exception Therapeutic procedure Central Nervous System | Chemotherapy | Investigational New Drugs Non-Cytotoxic | Adrenal Cortex Hormones High dose | Adverse effects of medical drugs Recovery Lacking

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C3714787
UMLS CUI [3]
C0392920
UMLS CUI [4,1]
C0013230
UMLS CUI [4,2]
C2827065
UMLS CUI [5,1]
C0001617
UMLS CUI [5,2]
C0444956
UMLS CUI [6,1]
C0810090
UMLS CUI [6,2]
C2004454
UMLS CUI [6,3]
C0332268
evidence of new york heart associatation class iii or greater cardiac disease.
Beschreibung

Heart Disease New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
history of myocardial infarction, stroke, or cardiovascular intervention within the last 12 months.
Beschreibung

Myocardial Infarction | Cerebrovascular accident | Intervention Cardiovascular

Datentyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3,1]
C0184661
UMLS CUI [3,2]
C3887460
patients on anti-platlet drugs or anticoagulants such as placix and coumadin.
Beschreibung

Antiplatelet Agents | Anticoagulants | Plavix | Coumadin

Datentyp

boolean

Alias
UMLS CUI [1]
C0085826
UMLS CUI [2]
C0003280
UMLS CUI [3]
C0633084
UMLS CUI [4]
C0699129
systemic central nervous system metastases. the patient must be stable after radiotherapy for >/= to 2 weeks and off corticosteroids for >/= to 1 week.
Beschreibung

CNS metastases Systemic | Stable status Post Therapeutic radiology procedure | Adrenal Cortex Hormones Discontinued

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205373
UMLS CUI [2,1]
C0205360
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C1444662
pregnant or nursing women.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who are primarily refactory to erlotinib.
Beschreibung

Erlotinib Refractory Primary

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1135135
UMLS CUI [1,2]
C0205269
UMLS CUI [1,3]
C0205225
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Non-small Cell Lung Cancer NCT00569114

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Non-small cell lung cancer recurrent TNM clinical staging | Pleural effusion
Item
histogically or pathologically determined relapsed/recurrent stage iiib (plueral effusion) or iv nsclc.
boolean
C0278517 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0032227 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease as defined by recist
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Chemotherapy Regimen Quantity failed | Chemotherapy Refused
Item
must have failed at least one prior chemotherapy regimen or have refused chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
ECOG performance status
Item
ecog perfromance status of 0,1, or 2.
boolean
C1520224 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria (include but are not limited to):
boolean
C0680251 (UMLS CUI [1])
Therapeutic radiology procedure | Exception Therapeutic procedure Central Nervous System | Chemotherapy | Investigational New Drugs Non-Cytotoxic | Adrenal Cortex Hormones High dose | Adverse effects of medical drugs Recovery Lacking
Item
radiation therapy (excluding cns therapy) < 2 weeks, chemotherapy, non-cytotoxic investigational agents or high dose corticosteroids within 3 weeks of intitating therpy or patients who have not recovered from adverse effects due to agents administered more than 3 weeks earlier.
boolean
C1522449 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C3714787 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3])
C0013230 (UMLS CUI [4,1])
C2827065 (UMLS CUI [4,2])
C0001617 (UMLS CUI [5,1])
C0444956 (UMLS CUI [5,2])
C0810090 (UMLS CUI [6,1])
C2004454 (UMLS CUI [6,2])
C0332268 (UMLS CUI [6,3])
Heart Disease New York Heart Association Classification
Item
evidence of new york heart associatation class iii or greater cardiac disease.
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Myocardial Infarction | Cerebrovascular accident | Intervention Cardiovascular
Item
history of myocardial infarction, stroke, or cardiovascular intervention within the last 12 months.
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0184661 (UMLS CUI [3,1])
C3887460 (UMLS CUI [3,2])
Antiplatelet Agents | Anticoagulants | Plavix | Coumadin
Item
patients on anti-platlet drugs or anticoagulants such as placix and coumadin.
boolean
C0085826 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
C0633084 (UMLS CUI [3])
C0699129 (UMLS CUI [4])
CNS metastases Systemic | Stable status Post Therapeutic radiology procedure | Adrenal Cortex Hormones Discontinued
Item
systemic central nervous system metastases. the patient must be stable after radiotherapy for >/= to 2 weeks and off corticosteroids for >/= to 1 week.
boolean
C0686377 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205360 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Erlotinib Refractory Primary
Item
patients who are primarily refactory to erlotinib.
boolean
C1135135 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video